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Apoptosis signal-regulating kinase 1 (ASK1) is linked
to neural stem cell differentiation after ischemic
brain injury
Juhyun Song1,4, Kyoung Joo Cho1,2,4, So Yeong Cheon1,2, Sa-Hyun Kim3, Kyung Ah Park1, Won Taek Lee1 and
Jong Eun Lee1,2
Neural stem cells (NSCs) have been suggested as a groundbreaking solution for stroke patients because they have the potential
for self-renewal and differentiation into neurons. The differentiation of NSCs into neurons is integral for increasing the
therapeutic efficiency of NSCs during inflammation. Apoptosis signal-regulating kinase 1 (ASK1) is preferentially activated by
oxidative stress and inflammation, which is the fundamental pathology of brain damage in stroke. ASK1 may be involved in the
early inflammation response after stroke and may be related to the differentiation of NSCs because of the relationship between
ASK1 and the p38 mitogen-activated protein kinase pathway. Therefore, we investigated whether ASK1 is linked to the
differentiation of NSCs under the context of inflammation. On the basis of the results of a microarray analysis, we performed
the following experiments: western blot analysis to confirm ASK1, DCX, MAP2, phospho-p38 expression; fluorescence-activated
cell sorting assay to estimate cell death; and immunocytochemistry to visualize and confirm the differentiation of cells in brain
tissue. Neurosphere size and cell survival were highly maintained in ASK1-suppressed, lipopolysaccharide (LPS)-treated brains
compared with only LPS-treated brains. The number of positive cells for MAP2, a neuronal marker, was lower in the ASK1-
suppressed group than in the control group. According to our microarray data, phospho-p38 expression was inversely linked to
ASK1 suppression, and our immunohistochemistry data showed that slight upregulation of ASK1 by LPS promoted the
differentiation of endogenous, neuronal stem cells into neurons, but highly increased ASK1 levels after cerebral ischemic
damage led to high levels of cell death. We conclude that ASK1 is regulated in response to the early inflammation phase and
regulates the differentiation of NSCs after inflammatory-inducing events, such as ischemic stroke.
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INTRODUCTION
Neurons are highly susceptible to damage; furthermore, dead
neuronal cells are not renewable or regenerable.1 These
neuronal characteristics make it difficult to successfully cure
neuronal disease. The activation of intrinsic neural stem cells
(NSCs) or the exogenous transplantation of NSC/neural
progenitor cells can be applied during neuro-regeneration.2
NSCs have been isolated by Reynolds and Weiss3 from the
adult brain and have the potential for self-renewal and
differentiation into neurons, astrocytes and oligodendrocytes.4
Endogenous, multipotent progenitor cells are located in the
subgranular zone of the hippocampus and the subventricular
zone (SVZ), where they proliferate; these cells can migrate to a
non-injured area and terminally differentiate into neurons.5
Differentiation of these stem cells is orchestrated by various
extrinsic and heritable, intrinsic factors that determine the
proper spatial and temporal cellular development.6 Various
stimuli that promote the neurogenesis of NSCs in vivo and
in vitro have been identified, for example, retinoic acid,
neurotrophins, steroid hormones and insulin-like growth
factor 1.7–9 The microenvironment that is established by
extrinsic and intrinsic factors must be optimal to differentiate
NSCs into specific cells in the damaged area.
Apoptosis signal-regulating kinase 1 (ASK1) has been
reported to regulate cell fate in many injury conditions and
disease models. ASK1 is a mitogen-activated protein kinase
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kinase kinase (MAPKKK, MAP3K) that is preferentially
activated by oxidative stress and inflammation. ASK1 has been
linked to the fundamental pathology of brain damage in stroke
and has essential roles in various cellular responses, such as
apoptosis, cell differentiation and immune responses. ASK1 is a
MAP3K that is involved in MAPK signaling pathways and
MAPK cascades.10 ASK1 activates the p38 MAPK and the c-jun
N-terminal-activating kinase pathways11 and eventually triggers
cell death. Our previous study demonstrated that after cerebral
ischemia in the mouse, ASK1 may be associated with neuronal
cell death. In addition to being an apoptosis signaling protein,
ASK1 has been reported to be a cell fate determinant for
NSCs.12 In addition, several reports have indicated that ASK1
could promote cellular differentiation and survival rather than
apoptosis, although these studies used non-neuronal cells.13,10
The findings suggest that ASK1 might have opposing functions
that are dependent upon cell type and status.
NSCs and neural progenitor cells have been demonstrated
to have a neuroprotective role by regulating inflammatory
responses in an injured area. Neurogenesis occurs in the
injured area, where newly born neurons migrate into the
infarct cortex and provide direct neurotrophic support and cell
replacement.14,15 Cellular apoptosis occurs during the early,
post-stroke inflammation phase. After stroke, modulating the
key factor in the early inflammation phase might be useful in
clinical therapeutics for treating ischemic stroke.
In this study, we investigated the effect of ASK1 signaling, an
early response to inflammation and other injuries, on the




Male C57BL/6 mice (Orient, GyeongGi-Do, Korea; 8- to 12-week old)
were subjected to transient focal cerebral ischemia by intraluminal
middle cerebral artery blockade with a nylon suture, as previously
described.16 After 60min of middle cerebral artery occlusion, blood
flow was restored by withdrawing the suture, and regional cerebral
blood flow was monitored using a laser Doppler flowmeter (Transonic
Systems, Inc., Ithaca, NY, USA). All animal procedures and experi-
ments were performed in accordance with the Guide to the Care and
Use of Laboratory Animals and were approved by the Association for
Assessment and Accreditation of Laboratory Animal Care.
Preparation of the ASK1 targeting siRNA
A small interfering RNA (siRNA) for ASK1 (Ambion, Austin,
TX, USA; sense, 50-GCUGGUAAUUUAUACACuGtt-30; antisense,
50-CAGUGUAUAAAUUACGAGCtt-30; conc, 5mM) was prepared to
silence ASK1 mRNA. Using an osmotic pump (Alzet, Cupertino, CA,
USA), a mixture of siPORT NeoFX (Ambion) and ASK1-siRNA was
administered into the cerebral ventricle (mediolateral 1.0mm; ante-
roposterior 0.2mm; dorsoventral 3.1mm) for 3 days before transient
focal cerebral ischemia.
For treating siASK1 on NSCs, siASK1 (5mM) was loaded at a DIV
of 3 and sustained for 3 days. Subsequently, western blot assays and
immunocytochemistry were performed on the NSCs as described
below.
NSC primary culture
Pregnant ICR mice were killed to obtain cortex NSC primary cultures
according to the method described by Gritti et al.17 Embryonic pup
brains were extracted from the ICR mice (E14) and placed in a Petri
dish containing Hank’s balanced salt solution (Gibco, Grand Island,
NY, USA), and each cortex was dissected and washed 1–2 times with
plain Hank’s balanced salt solution. To each tube of washed tissue,
5ml of Hank’s balanced salt solution was added and pipetted up and
down to dissociate the tissue. The NSCs were seeded in stem cell
media with EGF and bFGF supplements and were plated on poly-D-
lysine-treated plasticware. Cells were seeded at a low density for
imaging (3 105 cells per 35mm dish with coverslip; 2 105 cells per
well of six-well plate) or on a plate at a high density for biochemistry
(3 106 cells per well of six-well plate). The cells were cultured
for 3 days and were then treated with suitable drugs for each group.
Three days after treatment, the NSCs were used for the experiment.
Cultures were maintained in a humidified atmosphere of 95% air
and 5% CO2 at 37 1C.
Western blot analysis
Western blots were performed to elucidate the molecular mechanism of
ASK1 on the differentiation of NSCs. NSCs from each group were
cultured until 7 DIV, washed with phosphate-buffered saline, and then
collected by scraping the neurospheres from the plate. The collected
NSCs were homogenized in lysis buffer (1% Triton X-100, 0.5% NP-40,
150mM NaCl, 10mM Tris (pH 7.4), 1mM ethylenediaminetetraacetic
acid, 1mM EGTA pH 8.0, 0.2mM sodium orthovanadate, 0.2mM
phenylmethylsulfonyl fluoride and protease inhibitor cocktail) and
centrifuged (12000 r.p.m. at 4 1C) for 15min. Equal amounts of protein
(20mg) from the supernatants were separated on a 10% acrylamide gel,
and the proteins were electrophoretically transferred onto nitrocellulose
membranes. After blocking with Tris-buffered saline with Tween-20, the
blots were incubated with primary antibody overnight. The following
primary antibodies were used: b-actin (1:2000, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA), p38 (1:2000, Cell Signaling, Beverly, MA,
USA) and ASK1 (1:1000, Santa Cruz Biotechnology). The membranes
were then incubated with horseradish peroxidase-conjugated secondary
antibodies, the blots were rinsed, and the protein bands were visualized
using an enhanced chemiluminescence detection system (Amersham,
Piscataway, NJ, USA).
Flow cytometry analysis
Apoptotic cells were analyzed using the Annexin V-fluorescein
isothiocyanate apoptosis detection kit (Sigma, St Louis, MO, USA)
according to the manufacturer’s protocol. Neural progenitor cells were
dissociated by using Accumax cell detachment solution (Millipore,
Billerica, MA, USA). After centrifugation, the resulting suspension
was pelleted by centrifugation at 3000 r.p.m. for 3min at 4 1C and
then incubated on ice with Annexin V-fluorescein isothiocyanate and
propidium iodide. The cells were then incubated at room temperature
for 15min in the dark. A single-cell suspension was then collected and
resuspended in 500ml of fluorescence-activated cell sorting buffer and
analyzed using flow cytometry (FACSCalibur system, BD Biosciences,
San Jose, CA, USA). All fluorescence-activated cell sorting data were
analyzed using FlowJo software (TreeStar, Ashland, OR, USA).
Immunocytochemistry
To confirm the differentiation of NSCs, NSCs after 7 DIV were
washed three times with phosphate-buffered saline for immunostain-
ing and were blocked for 30min. The NSCs were then incubated with
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primary antibodies overnight at 4 1C. The following primary anti-
bodies were used: anti-MAP2 (1:200, Millipore), anti-SOX2 (1:200,
Millipore), anti-Ki-67 (1:200, Millipore) and anti-Nestin (1:200,
Millipore). After incubating the NSCs with the primary antibodies,
the plates were washed three times with phosphate-buffered saline for
5min and were incubated with rhodamine- or fluorescein isothio-
cyanate-conjugated secondary antibodies. The NSCs were then
counterstained with 4,6-diamidino-2-phenylindole for 10min at
room temperature. Immunostained NSCs were visualized using a
Carl-Zeiss confocal microscope LSM 700 (Carl Zeiss, Jena, Germany).
For immunohistochemistry, mice were killed at each time point,
and brains were post-fixed in PFA and cut into 20-mm-thick coronal
sections. Fluorescence immunostaining using SOX2 or Ki-67 anti-
bodies was performed, and images were acquired using a confocal
microscope LSM700 (Carl Zeiss).
Microarray analysis
Eight hours after cerebral ischemia, the brains of the mice were
homogenized with TRIzol reagent (Invitrogen, Carland, CA, USA)
according to the manufacturer’s recommendations. In addition,
Agilent’s Low RNA Input Linear Amplification kit (Agilent
Techno-
logy, Santa Clara, CA, USA) was used, and double-stranded DNA was
transcribed by adding the transcription master mix (4X transcription
buffer, 0.1M DTT, NTP mix, 50% PEG, RNase-out, inorganic
pyrophosphate, T7-RNA polymerase and cyanine 3/5-CTP) to the
double-stranded DNA reaction samples and incubating at 40 1C for
2 h. After testing the efficiency of labeling, the fragmented cRNA was
pipetted onto a Whole Human Genome Microarray Kit (4 44K;
Agilent Technology), and the hybridized microarrays were washed
following the manufacturer’s protocol. Using Agilent’s DNA micro-
array scanner, the hybridized images were scanned and quantified
using Feature Extraction (Agilent Technology) and GeneSpringGX7.3
(Agilent Technology) software, and all data were normalized and genes
of interest were selected by the fold change.
Data analysis
Statistical comparisons were performed by an independent t-test for
two groups or an analysis of variance using the SPSS (Statistical
Package for the Social Sciences, SPSS 18.0, IBM Corp, New York, NY,
USA) software program. The values are expressed as the mean±s.e.m.
of 3–6 experiments. Differences were considered significant at Po0.01
and 0.05.
RESULTS
Cerebral ischemic damage-induced cell death and
endogenous NSCs
Western blot analysis of ischemic stroke-injured mouse brains
at each time point showed that ASK1 protein levels were
maximized at 8 h and maintained these levels for 3 days. From
day 1, the amounts of ASK1 gradually decreased by 3 and 7
days, but the protein levels were higher than that of the control
(Figure 1a). At day 7, SOX2-positive cells were detected in cells
that were aligned with the SVZ (Figure 1b). The SOX2 protein,
which is a transcription factor, is essential for maintaining the
self-renewal, or pluripotency, of undifferentiated, embryonic
stem cells.
Eight hours after cerebral ischemia in mice, a significant


































Figure 1 Upregulation of the levels of apoptosis signal-regulating kinase 1 (ASK1) and endogenous neural stem cells after cerebral
ischemia. (a) Western blotting showed that the relative level of ASK1 was elevated from 8 to 24 h after cerebral ischemia in ischemic
lesions. b-Actin was used as an internal control (mean±s.d., n¼3–4). (b) Following cerebral ischemia for 7 days, SOX2-positive cells
(red) were observed in the subventricular zone of the contralateral and ipsilateral hemispheres. Hoechst 33258 was used as a
counterstain (blue). (c) The tables show significantly upregulated genes that were categorized as being related to inflammation or
neurogenesis by assessing the microarrays. Scale bar¼50mm; *Po0.1 compared with normal group.
Effect of ASK1 on NSC after inflammatory condition
J Song et al
3
Experimental & Molecular Medicine
(Figure 1c). The Affymetrix scatter plot shows the signal
intensity of upregulated genes in the ischemic group compared
with that of the normal group, specifically in the categories of
inflammation and neurogenesis. On the basis of the table, the
following elevated genes were involved in inflammation and
neurogenesis: inflammation—CCL2, CCL4 and interleukin-
1b; neurogenesis—Ascl2, Egr2 and P2ry2.
Downregulation of ASK1 influenced neurosphere formation
and cell death
It is well known that neuro-inflammation is induced after an
ischemic stroke; therefore, we evaluated this process using our
microarray data (Figure 1c). To investigate the role of ASK1 in
endogenous proliferation and NSC differentiation, NSCs from
a mouse cortex were cultured, and differentiation was induced
by lipopolysaccharide (LPS; 10 ngml–1) treatment. It was
confirmed that the treatment of NSCs with ASK1-siRNAs
decreased ASK1 protein expression, whereas the ASK1 protein
level was not significantly different in the control group, which
had been treated with siPORT NeoFX as a vehicle and a
scrambled siRNA as a negative control (Figure 2a). To confirm
gene silencing, a siRNA against glyceraldehyde 3-phosphate
dehydrogenase was used as a positive control.
Bright-field microscope images showed that LPS treatment
of NSCs decreased the size of the neurosphere compared with

























































































































































Figure 2 Relationship between cell death and differentiation in neural stem cells. The neurosphere size was measured by bright field
microscopy, and cell death was measured by FACS analysis. (a) GAPDH gene silencing was used as a positive control and reduced
the level of GAPDH protein. Downregulation was confirmed by western blot analysis (upper). Treatment with the ASK1-siRNA resulted in
decreased ASK1 protein levels in NSCs (lower). (b) Neurosphere sizes were maintained more in the ASK1-siRNA treatment group than
in the control group. (c) FACS analysis data show that the percentage of dead cells was lower in the ASK1-siRNA treatment group
than in the control group after LPS treatment. *Po0.1. ASK1, apoptosis signal-regulating kinase 1; FACS, fluorescence-activated cell
sorting; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LPS, lipopolysaccharide; NS, not significant; NSC, neural stem cell;
PI, propidium iodide; siRNA, small interfering RNA.
Effect of ASK1 on NSC after inflammatory condition
J Song et al
4
Experimental & Molecular Medicine
NSCs decreased to below 50% that of the control group
(Figure 2b). Neurosphere size data suggested the possibility
that suppression of the ASK1 gene allowed a NSC to maintain
its neurosphere in spite of the inflammation condition. To
investigate whether the suppression of the ASK1 gene was
linked to cell apoptosis, flow cytometry analysis was performed
at 6 DIV for each condition (Figure 2c). The flow cytometer
reads 50 000 cells per sample, and single cells were gated. The
propidium iodide and fluorescein isothiocyanate signals were
read, and each signal-positive cell was presented as a percen-
tage on the dot plot. Apoptotic cell death was compared
between treated groups by counting the Annexin V-positive
cells on the dot plot. The quantitative graph showed that ASK1
treatment significantly decreased the number of dead cells
compared with that of the negative control and increased the
mean diameter of the neurospheres at the same concentration
of seeding NSCs (3.0 104 cellsml–1).
ASK1 is linked to the differentiation of NSCs under
LPS-induced inflammation
Double fluorescent immunostaining results showed that the
level of DCX-positive cells, which is a NSC marker, was higher
in the LPS-treated than in the control group. In addition,
differentiation to mature neurons was detected by MAP2
(a marker of a mature neuron), which was increased by LPS
(Figure 3). In the immunocytochemistry analysis, it was
difficult to evaluate the changing pattern of DCX- and
MAP2-positive cells between treated groups. Therefore, wes-
tern blotting was performed to confirm the difference in the
proliferation and differentiation of NSCs.
In the LPS-treated group, more DCX-positive, NSCs and
MAP2-positive, mature neuronal cells were detected than in
the control group (Figure 4a). This result indicated that LPS
led to stem cell differentiation and proliferation. The results of
the western blot analysis after ASK1-siRNA treatment demon-
strated that ASK1-siRNA treatment significantly decreased
DCX and MAP2 protein expression to normal levels. In
contrast to the MAP2 level, the DCX protein level did not
undergo a dramatic increase after LPS treatment.
We hypothesize that LPS may have a more significant role in
the differentiation rather than proliferation of NSCs. In
addition, the inflammatory condition may initiate differentia-
tion by regulating the ASK1 level and its downstream cascades.
Based on previous microarray data, ASK1 is the link between
the MAPKs-p38 MAPK pathway and neurogenesis. Treatment























Figure 3 Photomicrographs of neural stem cells (NSCs) under apoptosis signal-regulating kinase 1 (ASK1) suppression conditions.
Immunofluorescence images of a neural stem cell (DCX, green) and mature neuron (MAP2, red). The number of MAP2-positive cells
increased after ASK1-small interfering RNA (siRNA) treatment in the lipopolysaccharide (LPS)-treated group compared with the LPS-only
treatment group. The lane furthest to the right presents results without the primary antibody as a negative control. The bottom row shows
the images after higher magnification.
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and govern cell death and cell fate, thereby regulating the
differentiation of NSCs (Figure 4b).
DISCUSSION
NSCs can possibly self-renew and differentiate into neurons
and other glial cells. We aimed to investigate the regulatory
effect of ASK1 on NSC differentiation and cell fate determina-
tion under controlled ASK1 downregulation. Our present
study showed the following: (1) inflammatory conditions such
as LPS treatment led NSCs to differentiate and caused cell
death. (2) Downregulated ASK1 could not stimulate NSC
differentiation. (3) After inducing inflammatory conditions
and augmenting ASK1, moderate levels of ASK1 may be
effective in differentiating NSCs and in preventing cell death.
Three populations of precursors, including adult NSCs, are
found in the SVZ, which is adjacent to a layer of ependymal
cells that line the lateral ventricle wall. These NSCs are known
to be relatively quiescent cells that express embryonic radial
precursors and the astrocyte protein GFAP. Initial studies
established the lineage and anatomical relationships of these
populations,18 but recent studies have expanded our NSC
knowledge to the adult SVZ niche.19–21 Here, we suggest that
ASK1, a MAP3K5, induces neuronal cell death in infarcted
areas and neuronal differentiation of NSCs in the SVZ.
Similarly, microarray data demonstrate that interleukin-1b, a
pro-inflammatory factor, was greatly increased, meaning that
inflammation was triggered by ischemic insults.
Our previous study also reported that LPS introduced into
the corpus callosum of mice increases interleukin-1b levels.22
We performed experiments under LPS-induced inflammatory
conditions. Under inflammation conditions that were induced
by cerebral ischemia, ASK1 levels remained significantly but
slightly increased compared with the control group at day 7.
Correspondingly, SOX2-positive cells were detected in the SVZ
at day 7 (data not shown), and it could be speculated that
moderate amounts of ASK1 were stimulated.23,24 Among the
neural subtype cell lineages expressing neural SOX2, MAP2 and
GFAP, the cells located in the SVZ expressed SOX2. SOX2-
positive cells can produce self-renewal cells and differentiate to
neuronal cells; therefore, they can be used as a stem cell marker.25
It has been reported that proliferation of SOX2-positive NSCs
can produce neural precursors and maintain NSCs.25
We investigated the role of ASK1 in the survival, prolifera-
tion and differentiation of central nervous system stem cells by
using NSCs. Our data showed that after LPS induction, NSCs
that had been treated with ASK1-siRNA had a significantly
higher number of cells displaying neuronal features compared
with those of control cultures. We also investigated the in vitro
effects of LPS and LPS with ASK1-siRNA on NSCs during
proliferation and differentiation. The proliferation rate was
evaluated through neurosphere formation assays. The size of
the neurosphere reflects the state of proliferation or differ-
entiation, and LPS caused the size of the neurosphere to
decrease. One explanation is that the NSCs formed a neuro-
sphere that began to differentiate. However, ASK1-siRNA
treatment increased the size of the neurosphere. These results
are consistent with those of a previous report that found that
ASK1 stimulated neuronal differentiation in adult hippocam-
pus-derived progenitor cells.26 Until now, the major role of
ASK1 was thought to be as an initiating factor for the MAPK
cascade and in regulating apoptosis signals.12,27
To determine the sub-population ratio of neuronal and glial
cells that respond to ASK1 levels, it would be necessary to
differentiate between those cells and analyze their responses to
ASK1. The previous study by Takeda et al.10 showed that the
survival and neuronal differentiation of undifferentiated PC12
cells were induced by ASK1, and this induction was dependent on
activation of the p38 MAPK. Owing to the different properties of
progenitor cells in the peripheral and central nervous systems,














































































































































Figure 4 Effect of apoptosis signal-regulating kinase 1 (ASK1) on
neuronal differentiation through the p38 mitogen-activated protein
kinase (MAPK) pathway. (a) DCX and MAP2 expression increased
in the ASK1-small interfering RNA (siRNA) treatment group
compared with the control group. (b) Phosphor-p38 expression
decreased more in the ASK1-siRNA and the ASK1-siRNA with
lipopolysaccharide (LPS)-treatment groups than in the LPS-only
treatment group. *Po0.1.
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be restricted to cells of the peripheral nervous system.
Nonetheless, another previous report demonstrated that ASK1
depletion increased GFAP promoter activity after treatment with
SB 203580.26 In addition, the inhibition of glial cell differentiation
is mediated by the p38 MAPK.26 Therefore, it remains to be
investigated whether neuronal fate is induced in pre-differentiated
precursors or only stimulated in neurons. It seems more likely
that glial differentiation in NSCs or early glial precursors is
prevented by ASK1.
Severe cerebral ischemic damage raises the possibility of
NSCs remaining in a state of quiescence, whereas mild hypoxia
brings about NSC proliferation and neuronal and oligoden-
droglial differentiation.28 Therefore, modulating the severity of
ischemic damage could provide an important advantage and a
useful tool for NSC-mediated therapy of ischemic stroke, and
alleviating the high ASK1 levels that occur because of brain
damage could aid in modulating this damage. Moderate
amounts of ASK1 may promote the differentiation of
endogenous stem cells into neurons, whereas downregulated
ASK1 levels could simultaneously prevent cell death within
damaged lesions. Therefore, regulating ASK1 to a moderate
level in an ischemic lesion after a severe injury may result in a
more favorable microenvironment. An increased under-
standing of ASK1 signaling during the differentiation of
NSCs may be potentially valuable for future, cell-based
therapeutic strategies for neuronal diseases.
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